-
CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD)
SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its
Lifestyle Content
Technology
-
Chinese Top Manufacturer Reshapes Sustainable Plug Valve Solutions for Worldwide Markets
-
Press Release Distribution Helps Companies Build a Broader Online Footprint
-
Top Activewear Manufacturer Driving Sustainable Excellence in Yoga Wear
-
The Mission Motif Highlights Arts and Crafts Living During Stickley Labor Day Sale
-
Conversational AI Creates a Direct Path From Customer Questions to Scheduled Appointments
Entertainment
-
Dmitriy Pingasov Uses Aviation Experience for Athlete Transportation and Personal Travel
-
Michles & Booth Named “The Official Law Firm of UWF Athletics”
-
Wine at 38: Solaire Resort Quezon City Brings Wine Appreciation to a New Level
-
Britain Shuts Out Millionaire Immigrants: The Curious Case of FCA vs Dolfin
-
Dominate Solutions Named Tampa’s Leading Web Design Agency Behind High-Converting Plumbing and Personal Brand Websites
Health
-
Lark Electric Joins American Gridwork Partners in Strategic Partnership to Accelerate Regional Growth and Expand Industrial Automation Capabilities
-
American Gridwork Partners Welcomes Three Additional Companies, Expanding Physical Infrastructure Platform Across the Southeast and Ohio Valley
-
KKR Invests in Malaysian Healthcare Platform Avisena Healthcare
-
Robbins LLP Informs Investors of the Unicycive Therapeutics, Inc. Securities Class Action
-
YSS INVESTOR ALERT: York Space Systems Inc. Investors with Substantial Losses Have Opportunity to Lead the York Space Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
